Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06430060
Other study ID # CRO-2024-03-GIN-DZN-CN-YPZ
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received
Last updated
Start date June 2024
Est. completion date August 2024

Study information

Verified date June 2024
Source Colgate Palmolive
Contact Deyu Hu, DDS, MS
Phone 86-1390-803-4990
Email hudeyu@vip.sina.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Qualified subjects will be enrolled and randomized to either one of the two study groups described above based on their initial Plaque and Gingivitis scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after three months of product use. All subjects will be followed for adverse events throughout the study.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Subjects, ages 18-70, inclusive. - Availability for the three-month duration of the clinical research study. - Good general health. - Minimum of 20 uncrowned permanent natural teeth (excluding third molars). - Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index. - Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification). - Signed Informed Consent Form Exclusion Criteria: - Presence of orthodontic bands. - Presence of partial removable dentures. - Tumor(s) of the soft or hard tissues of the oral cavity. - Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone). - Five or more carious lesions requiring immediate restorative treatment. - Antibiotic use any time during the one month prior to entry into the study. - Participation in any other clinical study or test panel within the one month prior to entry into the study. - Dental prophylaxis during the past two weeks prior to baseline examinations. - History of allergies to oral care/personal care consumer products or their ingredients. - On any prescription medicines that might interfere with the study outcome. - An existing medical condition which prohibits eating or drinking for periods up to 4 hours. - History of alcohol or drug abuse. - Pregnant or lactating subjects

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
zinc containing toothpaste
Toothpaste
MFP Fluoride toothpaste
toothpaste

Locations

Country Name City State
China West China Dental Institute of Chengdu Chengdu Sichuan

Sponsors (1)

Lead Sponsor Collaborator
Colgate Palmolive

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Loe-Silness Gingival Index score A Loe-Silness Gingival Index score from 0 to 3 will be assigned by the examining dentist to all scoreable surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth mean score for each subject will be determined by adding the values given by the examining dentist to each scoreable surface and dividing that number by the total number of surfaces scored. baseline, 2 week, 6 week, 3 month
Primary Quigley-Hein Plaque Index score A Quigley-Hein Plaque Index score of 0 to 5 will be assigned to all scoreable disclosed surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth score for each subject will be determined by adding the values given by the dental examiner to each scoreable surface and dividing that number by the total number of surfaces scored. baseline, 2 week, 6 week, 3 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05568290 - Interleukin-38 Levels in Individuals With Periodontitis
Completed NCT04402996 - Meteorin-like Levels in Individuals With Periodontitis
Not yet recruiting NCT06016023 - Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
Not yet recruiting NCT05497895 - The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients Early Phase 1
Completed NCT02884817 - Essential Oil+ELA, Plaque and Gingivitis Phase 4
Completed NCT02633345 - Effects on Tablets Containing Probiotic Candidate Strains N/A
Completed NCT02552589 - Effect of Toothpaste on the Reduction of Plaque and Inflammation N/A
Completed NCT02235532 - Effects of Aloe Vera Toothpaste on Periodontal Parameters N/A
Completed NCT02980497 - Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study N/A
Unknown status NCT01956656 - Efficacy Of Lotus Leaves In Management Of Plaque Induced Gingivitis N/A
Completed NCT02515929 - Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs Phase 4
Completed NCT01941797 - Experimental Peri-implant Mucositis in Humans N/A
Completed NCT02508987 - Obesity and Oxidative Stress in Patients With Different Periodontal Status N/A
Unknown status NCT01197105 - Evaluation Study of a Mouthwash Based on Schinus Terebinthifolius to Treat Gingivitis in Children Phase 1/Phase 2
Completed NCT01593540 - Clinical Examination of Metal Free Interdental Brushes Phase 4
Completed NCT01236963 - Essential Oils Mouth Rinse and Dental Floss: Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation N/A
Completed NCT02102295 - Effects of Antioxidant Dentifrice on Gingivitis Phase 3
Completed NCT06140784 - A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices N/A
Completed NCT02937636 - To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population N/A
Completed NCT06212908 - Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer N/A